January 14, 2014 - Acute Lymphoblastic Leukemia (ALL): Understanding Diagnosis & Treatment for Adults
Date: January 14, 2014
Time: 1:00 p.m. - 2:30 p.m. ET
View: Program Slides | Program Slides (Spanish)
Read: Transcript | Transcript (Spanish)
Listen: Presentation | Q&A Session | Presentation (Spanish) | Q&A Session (Spanish)
Access: Virtual Lecture
- How acute lymphoblastic leukemia (ALL) is diagnosed
- The importance of risk assessment when developing a treatment plan
- Current and emerging treatment options
- The role of clinical trials in the continuing improvement of treatment options
- Maintaining open communication with your treatment team
Dan Douer, MD
Memorial Sloan-Kettering Cancer Center
New York, NY
Questions Asked by the Adult ALL Community
- Doctor, you refer to event free survival- What is considered an event, and who is included in a five-year, event free survival?
- Can Ph+ (Philadelphia chromosome positive) ALL be healed completely? Do I have to take a TKI medication like Gleevec® for the rest of my life?
- What are the side effects of administering intrathecal methotrexate?
- Please talk about adult maintenance protocols. How long is the maintenance protocol?
- Would haploidentical transplants (half-matched donor transplants) be appropriate for adults?
- Is AVN (avascular necrosis) a common side effect of ALL treatment?
- Is radiation treatment appropriate for ALL patients?
- Since blood counts rise and fall while you are on maintenance, how would you know if you are relapsing?
- Can you determine how long one had leukemia prior to diagnosis?
- What is being done to minimize long-term and late effects such as cardiac function and neuropathy for patients with ALL?
- What are the advantages and disadvantages of clinical trials for adult ALL patients?
- Is it possible to be considered cancer-free, or will patients have to be tested for relapse for the rest of their lives?
- How important is MRD (minimal residual disease)?
- Is transplantation the only option for a relapsed adult ALL patient?
Sponsors and Supporters
This program is presented by The Leukemia & Lymphoma Society and sponsored by Amgen.